Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines.

Hopkins, Claire, Alanin, Mikkel, Philpott, Carl, Harries, Phil, Whitcroft, Katherine, Qureishi, Ali, Anari, Shahram, Ramakrishnan, Yujay, Sama, Anshul and Davies, Elgan (2020) Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. ISSN 1749-4486. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

[img] Text (PDF file format)
coa.13636 - Published Version
Available under License Creative Commons Attribution 4.0.

Download (17kB)
Official URL: http://onlinelibrary.wiley.com/journal/10.1111/(IS...

Abstract

OBJECTIVES

The primary aim of the study is to provide recommendations for the investigation and management of patients with new onset loss of sense of smellduring the COVID-19 pandemic DESIGN: After undertaking a literature review, we used the RAND/UCLA methodology with a multi-step process to reach consensus about treatment options, onward referral andimaging.

SETTING AND PARTICIPANTS

An expert panel consisting of 15 members was assembled. A literature review was undertaken prior to the study and evidence was summarised for the panellists.

MAIN OUTCOME MEASURES

The panel undertook a process of ranking and classifying appropriateness of different investigations and treatment options for new onset loss of sense of smell during the COVID-19 pandemic.Using a 9-point Likert scale, panellists scored whether a treatment was: Not recommended, optional, or recommended. Consensus was achieved when more than 70% of responses fell into the category defined by the mean.

RESULTS

Consensus was reached on the majority of statements after 2 rounds of ranking. Disagreement meant no recommendation was made regarding one treatment, using Vitamin A Drops. Alpha lipoic acid was not recommended, olfactory training was recommended for all patients with persistent loss of sense of smell of more than 2 weeks duration, and oral steroids, steroid rinses and omega 3 supplements may be considered on an individual basis. Recommendations regarding the need for referral and investigation have been made.

CONCLUSION

This study identified the appropriateness of olfactory training, different medical treatment options, referral guidelines and imaging for patients with COVID-19 related loss of sense of smell. The guideline may evolve as our experience of COVID-19 develops.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: WC Communicabable diseases
WV Otorhinolaryngology. ENT medicine
Divisions: Ambulatory Care > ENT
Related URLs:
Depositing User: Jamie Edgar
Date Deposited: 16 Sep 2020 11:33
Last Modified: 16 Sep 2020 11:33
URI: http://www.repository.uhblibrary.co.uk/id/eprint/3428

Actions (login required)

View Item View Item